Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 600 49 777.1 |
96 | EP file number | EAKZ | 14 16 9178.2 |
97 | EP publication number | EPN | 2803367 |
54 | Designation/title | TI | Verfahren zur Behandlung mithilfe von Anti-ERBB-Anitkörper-Maytansionoid-Konjugaten |
51 | IPC main class | ICM (ICMV) | A61K 47/68 (2017.01) |
22 | DE application date | DAT | Jun 23, 2000 |
96 | EP application date | EAT | Jun 23, 2000 |
43 | Date of first publication | OT | Nov 19, 2014 |
| Date of publication of grant | PET | Jan 31, 2018 |
71/73 | Applicant/owner | INH | ImmunoGen, Inc., Waltham, Mass., US |
72 | Inventor | IN | Blattler, Dr. Walter, Brookline, MA 02446-2768, US |
74 | Representative | VTR | ZACCO Patentanwalts- und Rechtsanwaltsgesellschaft mbH, 80335 München, DE |
| Address for service | | ZACCO Patentanwalts- und Rechtsanwaltsgesellschaft mbH, 80335 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 141316 P Jun 25, 1999
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 189844 P Mar 16, 2000
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| Published EP/WO documents | EPWOPN | Original document:
EP000002803367 Searchable text:
EP000002803367 Original document:
EP000002803367B1 Searchable text:
EP000002803367B1 |
43 | Date of first publication | EVT | Nov 19, 2014 |
| Date of the first transfer into DPMAregister | EREGT | Jan 1, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Jun 25, 2020 (Show all update days)(Hide all update days)- Jun 25, 2020; Aug 21, 2019; May 7, 2019; Jan 24, 2019; Dec 20, 2018; Jul 12, 2018; Mar 16, 2018; Mar 1, 2018; Jan 25, 2018; May 11, 2017
- Historical data not available for this/these date(s)
- Jan 1, 2015
- Date of the first transfer into DPMAregister
|